Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

PEI-g-PEG-RGD/small interference RNA polyplex-mediated silencing of vascular endothelial growth factor receptor and its potential as an anti-angiogenic tumor therapeutic strategy.

  • Authors : Kim J; Department of Chemistry, BK School of Molecular Science, Polymer Research Institute, Pohang University of Science and Technology , Pohang, Korea.; Kim SW

Subjects: Neoplasms/Neoplasms/Neoplasms/*drug therapy ; Neoplasms/Neoplasms/Neoplasms/*pathology ; Peptides, Cyclic/Peptides, Cyclic/Peptides, Cyclic/*administration & dosage

  • Source: Oligonucleotides [Oligonucleotides] 2011 Mar-Apr; Vol. 21 (2), pp. 101-7. Date of Electronic Publication: 2011 Mar 04.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print-Electronic

Record details

×
Academic Journal

G3139 and other CpG-containing immunostimulatory phosphorothioate oligodeoxynucleotides are potent suppressors of the growth of human tumor xenografts in nude mice.

Subjects: Adjuvants, Immunologic/Adjuvants, Immunologic/Adjuvants, Immunologic/*therapeutic use ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: Oligonucleotides [Oligonucleotides] 2006 Spring; Vol. 16 (1), pp. 83-93.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Therapeutic applications of DNA and RNA aptamers.

  • Authors : Thiel KW; Department of Internal Medicine, University of Iowa, Iowa City, Iowa 52242, USA.; Giangrande PH

Subjects: Aptamers, Nucleotide/Aptamers, Nucleotide/Aptamers, Nucleotide/*therapeutic use ; Infections/Infections/Infections/*drug therapy ; Neoplasms/Neoplasms/Neoplasms/*drug therapy

  • Source: Oligonucleotides [Oligonucleotides] 2009 Sep; Vol. 19 (3), pp. 209-22.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Chemical modification of siRNAs for in vivo use.

  • Authors : Behlke MA; Integrated DNA Technologies, Inc., Coralville, Iowa 52241, USA.

Subjects: RNA Interference* ; RNA Stability*; Macular Degeneration/Macular Degeneration/Macular Degeneration/*therapy

  • Source: Oligonucleotides [Oligonucleotides] 2008 Dec; Vol. 18 (4), pp. 305-19.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

A functionally improved locked nucleic acid antisense oligonucleotide inhibits Bcl-2 and Bcl-xL expression and facilitates tumor cell apoptosis.

Subjects: Apoptosis*; Neoplasms/Neoplasms/Neoplasms/*genetics ; Oligonucleotides/Oligonucleotides/Oligonucleotides/*pharmacology

  • Source: Oligonucleotides [Oligonucleotides] 2004; Vol. 14 (3), pp. 199-209.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Poly-2'-DNP-RNAs with enhanced efficacy for inhibiting cancer cell growth.

  • Authors : Chen X; Bioenergetics Laboratory, Natural Sciences Complex, University at Buffalo, Buffalo, NY 14260-3000, USA.; Shen L

Subjects: Dinitrobenzenes/Dinitrobenzenes/Dinitrobenzenes/*chemistry ; Dinitrobenzenes/Dinitrobenzenes/Dinitrobenzenes/*pharmacology ; Growth Inhibitors/Growth Inhibitors/Growth Inhibitors/*pharmacology

  • Source: Oligonucleotides [Oligonucleotides] 2004; Vol. 14 (2), pp. 90-9.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

siRNA-mediated integrin-linked kinase suppression: nonspecific effects of siRNA/cationic liposome complexes trigger changes in the expression of phosphorylated-AKT and mTOR independently of ILK silencing.

  • Authors : Verreault M; Advanced Therapeutics, British Columbia Cancer Research Center, Vancouver, British Columbia, Canada. ; Bally MB

Subjects: Drug Delivery Systems*; Neoplasms/Neoplasms/Neoplasms/*therapy ; Protein Kinases/Protein Kinases/Protein Kinases/*biosynthesis

  • Source: Oligonucleotides [Oligonucleotides] 2009 Jun; Vol. 19 (2), pp. 129-40.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Chitosan/short hairpin RNA complexes for vascular endothelial growth factor suppression invasive breast carcinoma.

  • Authors : Salva E; Department of Pharmaceutical Biotechnology, Faculty of Pharmacy, Marmara University, Istanbul, Turkey. ; Kabasakal L

Subjects: Chitosan/Chitosan/Chitosan/*administration & dosage ; Mammary Neoplasms, Experimental/Mammary Neoplasms, Experimental/Mammary Neoplasms, Experimental/*genetics ; Mammary Neoplasms, Experimental/Mammary Neoplasms, Experimental/Mammary Neoplasms, Experimental/*therapy

  • Source: Oligonucleotides [Oligonucleotides] 2010 Aug; Vol. 20 (4), pp. 183-90.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Decoy-DNA against special AT-rich sequence binding protein 1 inhibits the growth and invasive ability of human breast cancer.

  • Authors : Yamayoshi A; Department of Biomolecular Engineering, Kyoto Institute of Technology , Matsugasaki, Kyoto, Japan. ; Yasuhara M

Subjects: Genetic Therapy*; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*pathology ; Breast Neoplasms/Breast Neoplasms/Breast Neoplasms/*therapy

  • Source: Oligonucleotides [Oligonucleotides] 2011 Mar-Apr; Vol. 21 (2), pp. 115-21.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
Academic Journal

Inhibition of TGF-beta2 with AP 12009 in recurrent malignant gliomas: from preclinical to phase I/II studies.

  • Authors : Hau P; Department of Neurology, University of Regensburg, Germany.; Jachimczak P

Subjects: Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*therapeutic use ; Brain Neoplasms/Brain Neoplasms/Brain Neoplasms/*drug therapy ; Glioma/Glioma/Glioma/*drug therapy

  • Source: Oligonucleotides [Oligonucleotides] 2007 Summer; Vol. 17 (2), pp. 201-12.Publisher: Mary Ann Liebert, Inc Country of Publication: United States NLM ID: 101188415 Publication Model: Print Cited

Record details

×
  • 1-10 of  38 results for ""Neoplasms""